Jeevtronics Pvt Ltd. The statement released by DBT said, “The affordable, low-weight device is considered more reliable than traditional defibrillators by experts as it can be used even in the areas where electricity is unavailable”.
The device does not require any battery change and operates with both AC mains and a hand-cranked generator incorporated within the unit. According to the start-up, the battery of the device has been tested for a significant number of charge-discharge cycles to make it more economical. The gadget is suitable for hospitals in urban as well as rural settings. According to the data given by the start-up, more than 200 devices have been distributed and employed all over India and Africa to date.
Jeevtronics has already been granted four patents in the United States and India, and has previously received financial assistance from the Biotechnology Industry Research Assistance Council (BIRAC). According to the start-up, SanMitra 1000 HCT is created adhering to international IEC standards for medical devices, and the cost of the patented technology is INR 99,999 plus taxes, which is much affordable than the other MNC big brands.
These defibrillators are normally used instead of chest compressions for CPR. They can also help COVID-19 individuals who have problems with their heartbeat rate or rhythm or Arrythmias. The company stated that it has also built the sole made-in-India ambulance-grade defibrillator known as the JeevtronicsSanMitra 1000 HCT EMS that has been evaluated at ARAI and will be priced at an economical cost compared to the cost of multinational company brands.
